Skip to main content
Sotirios Tsimikas, MD, Cardiology, San Diego, CA

Sotirios Tsimikas MD

Cardiology•San Diego, CA

Interventional Cardiology

Professor, Medicine, UCSD School of Medicine

Join to View Full Profile

  • 200 W Arbor DrSan Diego, CA 92103

  • Phone+1 858-657-8530

  • Fax+1 858-657-8021

Dr. Tsimikas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Tsimikas' Full ProfileAlready have an account?

Education & Training

  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterFellowship, Cardiovascular Disease, 1992 - 1996
  • UMass Chan Medical School
    UMass Chan Medical SchoolResidency, Internal Medicine, 1988 - 1991
  • University of Massachusetts Medical School
    University of Massachusetts Medical SchoolClass of 1988

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1991 - 2025
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
  • Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

Journal Articles

  • Lipoprotein(A) Reduction in Persons with Cardiovascular Disease  
    Sotirios Tsimikas, MD, The New England Journal of Medicine
  • Lipoprotein(A) Reduction in Persons with Cardiovascular Disease  
    Sotirios Tsimikas, MD, The New England Journal of Medicine
  • Lipoprotein(A) Reduction in Persons with Cardiovascular Disease  
    Sotirios Tsimikas, MD, The New England Journal of Medicine
  • Join now to see all

Authored Content

  • The Role of Lipoprotein(A) in Calcific AV Disease and Insights into Its Medical TherapiesApril 2020
  • The Role of Lipoprotein(A) in Calcific AV Disease and Insights into Its Medical TherapiesApril 2020
  • Lipoprotein(A) Reduction in Persons with Cardiovascular DiseaseJanuary 2020
  • PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes with a Human Antibody Detects Clinically Relevant AtherothrombosisJanuary 2018
  • Join now to see all

Press Mentions

  • JACC - Oxidized Phospholipids and Calcific Aortic Valvular Disease
    JACC - Oxidized Phospholipids and Calcific Aortic Valvular DiseaseNovember 20th, 2024
  • High Lp(A) Linked to ASCVD Risk Even When LDL Cholesterol Is Low
    High Lp(A) Linked to ASCVD Risk Even When LDL Cholesterol Is LowNovember 13th, 2024
  • Lp(A) Packs a More Powerful Atherogenic Punch Than LDL
    Lp(A) Packs a More Powerful Atherogenic Punch Than LDLJanuary 29th, 2024
  • Join now to see all

Grant Support

  • Aspirin, Lp(a) and Primary Prevention of Cardiovascular EventsUNIVERSITY OF CALIFORNIA, SAN DIEGO2023–2027
  • Aspirin, Lp(a) and Primary Prevention of Cardiovascular EventsUNIVERSITY OF CALIFORNIA, SAN DIEGO2023–2027
  • Translating Lp(a) biology to clinical applicationsUNIVERSITY OF CALIFORNIA, SAN DIEGO2022–2026
  • Translating Lp(a) biology to clinical applicationsUNIVERSITY OF CALIFORNIA, SAN DIEGO2022–2026

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Sotirios Tsimikas, Dr. Sotirios Tsimikas, MD, Dr. S Tsimikas